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I-N a recent conimunication in this Journal (Bloom, 1950)) the significance of
the histological architecture of the tumour in cases of mammarv carcinoma was
investigated. By employing a simple system of grading a close relationship was
revealed between histologv and prognosis.
A classification based upon the microscopic appearance of the tumour (grade)
combined with a knowledge of its extent (stage) was found to give a far more
accurate grouping of cases, and also provide a more reliable guide to prognosis
than could be achieved by either a system ofgrading or staging alone. Further-
more, by considering the cases according to our clinico-pathological subdivisions.
light was thrown upon some hitherto unexplained problems concerning the
results oftreatment.
The present paper is a continuation of the above work. It is the object now
to investigate some further aspects of prognosis in breast cancer on which, from
time to time, widely differing opinions have been expressed. What are these
problems, and why have they given rise to confusion ?
Istheprognosis in carcinoma ofthebreastinfluencedby theageofthepatient?
What is the effect on prognosis ofdelay in seeking treatment ? Has the size and
also the site of the primary growth any bearing on outcome ? These questions
will be studied presently, and the significance of the histological grade of malig-
nancy of the tumour will be considered in relation to them.
Material.
The same series of cases employed in our first communication will be used for
the present enquiry. It is made up of 565 cases of breast cancer treated at the
Mliddlesex Hospital during the years 1936 to 1942, and at the associated War
Sector Units during the latter half of this period. From these patients 95 must
be excluded for various reasons already considered (Bloom, 1950) thus leaving us
with 470 available for the investigation.
JMethod of Grading.
The system of histological grading introduced into this country by Patey and
Scarff (1928) will be used. This is based upon the principles formulated by
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Greenough (1925) in America, but chief importance is attached to the degree of
tubule formation, regularity in size and staining of nuclei, and the number of
hyperchromatic and mitotic figures. Three classes of tumour are recognized and
designated Grade I, Grade II and Grade III, thereby indicating carcinomata of
low, intermediate and high degrees of malignancy, respectively. Further details
ofthis method ofgrading may be found in our previous report (Bloom, 1950), the
system proving both simple to apply and remarkably effective in determining
possible outcome. The five-year survival rates for the three classes of tumour
were as follows: Grade I, 79 per cent; Grade II, 42 per cent, and Grade III,
25 per cent.
Asses8ment ofProgno8i.
The prognostic yard-stick will be the five-years' survival rate. It must be
pointed out that " survival rate " does not necessarily imply freedom fromcancer;
it is merely an indication ofthe number of patients actually alive.
AGE AND PROGNOSIS.
Many authors consider age to have an important bearing on prognosis in
cancer of the breast. Lee and Stubenbord (1928) have included a factor for age
in their clinical classification which has been employed recently by Richards
(1948).
It is widely believed that the younger the patient with malignant disease, the
more gloomy the outlook. In the case of mammary carcinoma this view is held
by MacCarty and Sistrunk (1922), Perry (1925), Daland (1927), Stout (1932),
Nathanson and Welch (1936), Kunath (1940), Cade (1940) and Pack and Living-
stone (1940).
Breast canceroccurringbeforetheageof30 is often regarded asbeingextremely
fatal, and Haagansen and Stout (1943) point out that some surgeons go so far
as to decline to operate upon such cases. Lee (1931) made a special study ofthis
disease in young women. He investigated 191 cases treated by radical surgery
with or without ancillary radiotherapy; all were under the age of40. The three-
year survival rate was 40 per cent, and only 16 per cent were without obvious
metastases. The author concluded that " cancer of the breast in young women
is a much more menacing disease than it is in mid-life or in old age." It is true
that these results may be poor for such a short period offollow-up, but attention
must be drawn to the fact that no control series of older patients treated at the
same clinic was available for comparison. In addition, when the survival rate
was determined for various age groups under 40 the results were found to be
practically identical. Furthermore, there were 25 cases of lactation cancer in
the series, and these should have been considered separately as they represent a
special, well-recognized problem. The effects ofpregnancy or lactation on breast
cancer will be referred to later.
At the Middlesex Hospital, Lazarus-Barlow and Leeming (1924) made their
classical study on the natural duration oflife for cancer ofvarious organs. With
regard to the breast, 243 cases, seen between the years 1883 and 1922, were
available for study. The authors revealed a parallel between age and outcome,
the mean duration of life becoming greater with advancing years.
We must now turn and consider the opposite view, that age is of no prog-
nostic significance. de Cholnoky (1943) reported the findings in a series of cases,
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all under the age of30. Fifty-nine patients were treated by a radical mastectomy
with a five-and ten-year survival rate of41 per cent and 37 per cent respectively.
Theseresultsarerelatively good. Infact, theyareevensuperiortothoseobtained
inageneralseriesstudiedbythesame author-34 per centfive-year and 22per cent
ten-year survival rates (Eggers, de Cholnoky and Jessup, 1941).
Hawkins (1944), in an investigation ofsome 2,600 cases showed a comparable
five-year survival rate in three age groups, namely, 49 and less, 50 to 59 and over
60. The author concluded that these findings do not support the fiequent
contention that the younger cancer patients have a worse outlook than the older
groups.
Age was not found to be an important factor in prognosis by Wyard (1925),
Greenwood (1926), Evans and Leucutia (1930), Lewis and Reinhoff (1932),
Matthews (1933), Scarf and Handley (1938), Macdonald (1942), Hoopes and
McGraw (1942), Haagensen and Stout (1943), Truscott (1947) and Harnett (1948).
Lane-Claypon (1924) in her survey for the Ministry ofHealth demonstrated a
similar survival rate among some 500 cases classified according to decade. In a
further paper (Lane-Claypon, 1928) some 1,800 cases were divided into three age
groups-less than 40, 40 to 50, and 60 and over. From a study ofthe survivals
for each group, the author concluded that "the statement commonly made that
the prognosis is worse in younger persons is erroneous."
More recently, Harrington (1946) in a large series of cases from the Mayo
Clinic found no relationship between age and the number of survivals at five
years. In addition, the effect ofage on the incidence of axillary metastases was
investigated. The proportion of cases with this complication were found to be
comparable in the majority of groups. Similarly, 59 per cent of the young
patients reported by de Cholnoky (1943) had axillary involvement compared with
64 per cent in the same author's general series (Eggers, de Cholnoky and Jessup,
1941).
Can a relationship between age and prognosis be shown in the present series ?
The age was available in 461 cases. The youngest patient was 22 and the oldest
80. Table I displays the five-year survivals in the various decades. The results
of a broader grouping are also presented (Table HI).
If we examine Table I it is evident that there is considerable fluctuation in
the percentage of survivals in the different groups. No parallel is revealed




<40 . 45 . 19 42
40-9 . 145 . 84 58
50-59 . 136 . 66 49
60-69 . 87 . 33 38
70+ . 48 . 24 50
between age and outcome, and there is no support for the view that the tumours
of younger women, apart from those associated with pregnancy and lactation,
kill more rapidly. Ofpatients aged 39 or less, 42 per cent were alive at five years
compared with 38 per cent in the seventh decade. When the cases are separated
out, as in Table II, it is clear again that the younger patients fare no worse than
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do the older ones, in fact, if anything, they do rather better. This has also been
the finding of Lane-Claypon (1928) and Hawkins (1944).
TABLE II.-Age and Prognosis.
a-year survivals. Age. Cases.-
No. Per cent.
<50 . 190 . 103 54
50-59 . 136 . 66 49
60± . 135 . 57 42
Geschickter (1945) believes that certain unfavourablefeatures exist foryounger
women with breast cancer, but that these are compensated for by the fact that
such patients, as shown by Kaae (1948), tend to seek medical advice sooner than
do older groups. Where the prognosis has been found to be comparable for
various ages it may be argued that this factor has come into operation. Hence.
it may not be adequate to consider the prognostic significance of age purely from
the results oftreatment.
Many authors who claim a parallel to exist between age and outcome maintain
that the breast cancers of younger women tend to be more anaplastic and grow
more rapidly than do those in older women. If this is true one would expect to
find a greater proportion ofgrowths ofhigh grade malignancy among the younger
cases, and a preponderance of low grade tumours in the older groups. Such a
discovery would be conclusive evidence for the view that the younger the patient
the graver the outlook. Now, several workers have shown that the degree of
malignancy in mammary carcinoma can be ascertained by examining a section
ofthe tumour. Attempts, however, to correlate the histologyv of cancer with age
appear to have been rarely performed. Up to the present time only two investi-
gations of this type have been found in the literature (Taylor, 1936 Lees and
Park, 1949). A study on these lines will now be made.
TABLE III.-Age, Grade and Prognosis.
Cases.
Age. Grade. - - -
No. Per cent.
<40 . I . 10 22- 2
II . 22
III . 13 28- 9
40-49 . I . 45 31-0
II . 58
III . 42 29 0
50-59 . I . 39 28-7
II . 59
III . 38 27*9
60-69 . I . 26 29- 9
II . 37
III . 24 27-6
.0+ . I . 16 33-3
II . 16
III . 16 33-3
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Table III has been constructed to show the relationship between age and
grade of malignancy in breast cancer. An examination of this table reveals a
really remarkably even distribution oftumours oflow and high grade malignancy
in the various decades. Not only is the proportion of Grade I and also of
Grade III cases similar in the different groups, but in addition the incidence
of these tumours is practically identical in the individual groups. Thus we
can find no support whatsoever in the present study for the thesis that cancer of
the breast is more malignant in younger than it is in older patients. These
results, however, are not in agreement with those obtainedby Tavlor (1936) who
also employed the principles of grading laid down by Greenough (1925). He
found a smaller numberoflow and agreaternumberofhighgrade tumours among
younger women when compared with an older group. On the other hand, the
conclusions reached by Lees and Park (1949), who have recently investigated the
relationship between histology and age for cancer in various organs including the
breast, agree with our findings and not with those ofTaylor (1936).
DURATION OF SYMPTOMS AND PROGNOSIS.
Generally speaking, the delay in seeking medical advice after the onset of
symptoms in breast cancer is becomig shorter. Towards the end of the last
century we find Dietrich (1892) reporting only 23 per cent of cases in a series as
having symptoms lasting less than six months. Reports from many sources
indicate that the proportion of patients attending hospital within this time has
gradually increased over the course ofthe last fifty years. For example, accord-
ing to Harrington (1946)33 per cent ofthe cases seen at the Mayo Clinic between
the years 1910 and 1914 were operated upon within six months and 54 per cent
within one year of the first symptom. These percentages climbed steadily,
reaching 50 and 70 respectively for the period 1935 to 1939.
In the present study data regarding the length ofthe history were available in
406 cases. Of these, 65 per cent came for treatment within six months of the
first symptom and 85 per cent within one year. Similar percentages are given by
Kaae (1948). In spite ofthe improvement, compared with earlier investigations,
these figures are still far from satisfactory. On the other hand, reports from
elsewhere are much more gloomy. Lewis and Reinhoff (1932) find as few as 34
per cent of their cases seeking medical advice within six months and 63 per cent
within one year. Even more recently, Eggers, de Cholnoky and Jessup (1941)
quote only 37 per cent and 55 per cent for correspondingintervals oftime.
The symptoms of mammary carcinoma and their frequency are dealt with
adequately by many authors. Suffice it here to say that by far the commonest
initial symptom has always been a lump in the breast. Forty-five years ago
Campiche and Lazarus-Barlow (1905) made a study ofnearly 2,000 patients seen
at the Middlesex Hospital between the years 1747 and 1903, and found this
feature present in 63 per cent. Later, at the same hospital, Beckton (1909) gave
an incidence of 70 per cent. More recent authors report even higher figures.
Thus, Harnett (1948) and also Cade (1940) find a lump to be the first symptom in
77 per cent of cases, Truscott (1947) in 84 per cent and Putzki and Scully (1946)
in 88 per cent. The " duration ofsymptoms," therefore, in the vast majority of
cases refers to the length of time a tumour has been present in the breast-from
the time the patient found it to the time she attended the hospital clinic.
The responsibility forprolonged delay before the institution oftreatment may
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be entirely that of the patient, but not always. Medical practitioners are occa-
sionallv guilty of wasting time, especially with regard to younger women when
cancer is not suspected. Kaae (1948) found that in his series three-quarters of
the cases were subjected to adequate therapy within one month and 90 per cent
within six months of the first medical examination. Lane-Claypon (1926)
reported a mean interval of five to six months between the consultation and
operation among 670 cases.
Whenever the management ofmalignant disease is discussed the importance of
early diagnosis and early treatment are emphasized. In the case of mammarv
carcinoma, has the duration of symptoms anv bearing on prognosis ? The
general teaching has certainly always been that the greater the delay in seeking
treatment in this disease the worse the outlook. The impression is also frequently
given that if a patient receives earlv therapy the prognosis is necessarily good.
These views meet with almost universal acceptance, and only very rarely have
thev been questioned. Are they in point offact well-founded ? For ifthey are,
we should direct more attention to reducing the tragically large numbers of
women who, through fear or ignorance, fail to seek medical care until many
months have elapsed following the discovery of a lump in the breast. If we can
accomplish this, will the number ofsurvivals at five and ten years after operation
increase ? Mlanv authorities believe thev will.
Let us now consider the opinions which have been expressed regarding the
duration of symptoms and prognosis. Luff (1932), in an investigation of over
1,500 cases for the British MLNedical Association, found that the longer the delay
between the first symptom and operation the more gloomy the outlook, as shoWn
by the survival, recurrence and mortality rates (Table IV). A study ofthis table
reveals that with a delay of twelve months the survival rate is halved and the
recurrence rate more than doubled. Cade (1950) refers to Luff's work and states
that" the mortality ofcancer ofthe breast inEngland and Wales could be reduced
from 7,000 yearly to 1,000, if all cases were adequately treated in the first month
ofthe appearance ofthe disease."
TABLE IV.-Prognosis and Duration of Symptoms (Luff, 1932).
Delay in 4-year survival Post-operative Mortality
months. rate. recurrence. rate. Cases per cent. Cases per cent. Casesper cent.
<1 . 31 . 14 . 5
1-3 . 29 . 14 . 17
3-6 . 24 . 27 . 16
6-12 . 24 . 27 . 26
> 12 . 16 . 35 . 37
Davis (1938), after studying a small series of 75 cases, considers that one of
the most important factors in determining prognosis is the delay in treatment.
He states that early diagnosis and therapy are essential in the ' cure ' of cancer
of the breast, and raises the question of advisability of surgery for patients with
a long history.
Hoopes and McGraw (1942) found that the percentage of five-year survivors
diminished slightly with increase in duration of symptoms, regardless of whether
or not the axillarv glands were invaded.
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Macdonald (1942), in a large series of cases, revealed that the greatest pro-
portion offive-year survivals were among those treated within two months ofthe
tumour being discovered. After this period a rapid deterioration in results
occurred. Witha delay ofoneyear, however, it wassurprisingtofindthenumbers
alive increasing. Similar results were obtained by Eggers, de Cholnokv and
Jessup (1941), who report a five-year survival rate of 76 per cent for patients
operated upon within one month. Here again, the results deteriorated rapidly
with increasing duration ofsymptoms, falling to 20 per cent for a delay of one to
two years. With further loss of time. however, the results improved, from 25
per cent for alapse oftwo to threeyears to 41 per cent for aneven greaterinterval.
From the preceding data it would appear that duration of symptoms has a
direct bearing on prognosis-the longer they have been present the worse the
outlook. The significance of the increase in the survival rates after a delay of
one or moreyears, as found by Mfacdonald (1942) and also by Eggers. de Cholnokv
and Jessup (1941), will be discussed later.
What can be revealed in the present series of cases as to the relationship
between delay in seeking treatment and prognosis ? Information regarding this
point was available in 406 instances. The five-vear survivals were determined
according to the duration of symptoms, and these are displayed in Table V. It
TABLEV XL.-luration of Symnptoms and Prog-niws3.
5-vear survivals.
Duration of svmptoms. Cases.
No. Per cent.
6 weeks or less . 101 . 50 50
3 months or less . 184 . 94 51
3-6 months . 125 . 59 47
6-12 months . 118 . 56 47
12 months or more 105 . 55 52
is to be noted that some overlap occurs in the various groups. Examination of
this table shows atruly remarkable state ofaffairs. Thesurvival rate is uniform,
no matter how long the history. We are not able, therefore. to agree with the
findings of Luff (1932), Davis (1938), Eggers, de Cholnoky and Jessup (1941),
Hoopes and McGraw (1942) and Macdonald (1942). Our results also appear to
conflict with generally accepted views, but thev are not unique. Lewis and
Rienhoff (1932) in 950 cases, Hawkins (1944) in over 3,000 cases and Kunath
(1940) consider that duration of symptoms. per se, are oflittle prognostic signifi-
cance.
This problem must be now examined more closely. So far, we have studied
the cases as a whole. No attempt has been made to classify them, and the
importance of this procedure has been stressed elsewhere (Bloom, 1950). What
types of cases are present in the various groups shown in Table V? It is possible
that thesegroups are not comparable. Forexample, theremav be apreponderance
of highly malignant tumours among the women attending hospital within the
six-week period, whilst there exists but a small proportion of similar growths
among those delaying for one year or longer. Such a distribution may compen-
sate for the difference in time, and thus account for the practically identical end-
results.
Cases ofbreast cancer may be classified by clinical stage or histological grade.
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Let us first ofall consider the scatter ofthe patients according to stage and dura-
tion of symptoms. For this purpose the Manchester svstem was employed, a
summary ofwhich may be found in our previous report (Bloom, 1950). Although
this classification depends upon clinical data, glandular involvement was deter-
mined, where possible, by microscopic examination; the reasons for this have
been dealt with in the same communication.
Reference to Table VI shows that with increasing length of history there is a
progressive fall in the proportion of cases at an early stage (Stage 1). A similar
TABLE VTI.-Dktri6ution of cases according to Duration of Symptams and
Clinical Stage.
Total Cases in Cases in Cases in Cases in Total. Duration ofsymptoms. cases. Stage 1. Stage 2. Stage 3. Stage 4. P
Per cent. Per cent. Per cent. Per cent. Per cent.
6weeks or less . 101 . 39 . 38 . 19 . 4 100
3 months or less . 184 . 37 39 . 19 . 5 . 100
3 to 6 months . 125. 35 . 34 . 23 . 8 . 100
6 to 12 months .118. 33 . 30 . 31 . 6 .100
I vear or more . 105 25 . 21 . 44 . 10 . 100
state of affairs is seen for those in Stage 2. On the other hand, the advanced
cases (Stages 3 and 4) increase in number with prolonged delay. In other words,
as more and more time elapses from the onset of the disease, as determined bv
the patient, so the early and moderately advanced tumours fall in number whilst
the proportion of more extensive growths becomes greater.
These results deserve no special comment. They are what one expects and
support the conclusions of Kaae (1948) that " with increasing duration of symp-
toms the number of Stage 1 cases becomes steadily less and there is a gradual
increase in the number of inoperables. . . .' On the other hand, these
findings make it even more difficult to understand those shown in Table V. For
instance, the percentage ofStage 1 and Stage 3 cases among the patients present-
ingwithinsix weeksofthefirst symptom is 39per cent and 19 per cent respectively
(Table VI). After a delay of one year or more the proportion ofearly cases falls
to 25 per cent, whilst the advanced cases increase to 44 per cent. And yet, in
spite ofthis, the five-year survival rate is practically the same-O0 per cent for
those having a delay of six weeks or less compared with 52 per cent for those
waiting one year or longer (Table V).
Will astudyofthehistologicaltype oftumourthrowany light ontheproblem ?
The distribution ofcases according to duration ofsymptoms and grade have been
drawn out in Table VII. A comparable percentage of Grade I tumours is seen
TABLE VIJ.-Distribution of C&ses According to Duration of Symptoms and
Histological Grade.
Total Cases in Cases in Cases in
Duration ofsymllptoms. cases Grade I. Grade II. Grade III. Total.
Per cent. Per cent. Per cent. Per cent.
6 weeks or less . 101 . 24 . 45 . 31 . 100
3 months or less . 184 . 25 . 45 . 30 . 100
3 to 6 months . 125 . 23 . 4 . 30 . 100
6 to 12 months . 118 . 33 . 40 . 27 . 100
I year or more . 105 . 38 . 34 . 28 . 100
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among the patients attending hospital within six weeks, three months and three
to six months ofthe first symptom. A similar state of affairs exists for Grade II
and alsoGradeIIIcarcinomas. Afterthistime, however, there is anincrease inthe
proportion of Grade I cases, and a reduction in those belonging to the higher
grades of malignancy. These changes, although not marked, may indicate that
the more virulent tumours tend to present sooner than the ones of lower malig-
nancy.
Let us investigate this matter further bv considering the delay in seeking
treatment of the cases according to the grade of tumour. Table VIII has been
TABLE VIII.-Percentage of Ca8es in Each Histoklical Grade According to
Duration ofSymptoms.
Duration of symptomas in months.
Grade. 6 or less. 7 to 12. More than 12.
Cases Cases Cases Total
per cent. per cent. per cent. per cent.
I . 56 . 21 . 23 . 100
II . 70O . 18 . 12 . 100
III . 69 . 21 . 10 . 100
constructed on a broader basis than Table VII, three periods only being taken.
namely, less than six months, between seven and twelve months and more than
one year. These results lend more weight to the view that patients with tumours
ofhigh malignancy tend to consult theirdoctors earlierthan dothose withgrowths
of low malignancy. In addition, the mean duration of symptoms for the three
classes of tumour are presented in Table LX. Here again there is evidence that
TABLE IX.-Mean Duration ofSymptom According to Grade.
Grade. Cases. Mean duration ofsymptoms
in months.
I . 124 . 10.1
II . 174 . 7.6
III . 125 . .1
Total . 423 . 8.3
the most malignant neoplasmas are associated with the shortest histories. This,
presumably, depends upon the rate of growth of the cancer, the higher grades
growing more rapidly. Thus, larger tumours are discovered more easilv, and a
rapid increase in size alarms the patient to seek medical advice at an early date.
The small, slowly growing tuimours of low grade malignancy may be regarded by
patients. at first, as not being serious. and so more time elapses before the medical
consultation.
Let us summarize briefly what has been said so far: Opposing views regarding
the effect ofdelay in seeking treatment on prognosis have been considered. From
our own series we have not been able to show, in spite ofthe findings in Table VI
that outlook becomes more gloomy with increasing delay. It was only when
the histological grade of malignancy was studied that some light was thrown on
the problem. It appears that the distribution ofthe types ofcarcinoma compen-
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sate to some extent for the time factor. With regard to the reports of other
workers, it may well be that the conflicting results obtained depend upon the
comparison ofhistologically incomparable groups of cases.
In view of these findings let us once again consider the relationship between
duration of symptoms and prognosis, but this time according to the grade of
malignancy (Table X). It is evident that outcome is now shown, in certain cases.
TABLE X.-Duration of Symptrnms and Prognosis According to Histological
Grade.
Grade I. Grade IL. Grade III.
Duration of symptoms. Alive at Alive at Alive at
Cases. a years. Cases. .5 years. Cases. 5 vears.
Per cent. Per cent. Per cent.
6 weeks or less . 24 . 92 . 46 . 41 . 31 . 29
3 months or less 45 87 . 83 . 47 . 56 29
3 to 6 months .28. 86 .59 42 .38. 26
6 to 12 months . 39 . 72 47 . 43 . 32 . 25
1 vear or more . 40 . 78 . 36 . 50 . 29 . 21
to be influenced by the length of history. Examination of this table in greater
detail allows the following conclusions to be reached. The delay in seeking
medical advice appears to be of some importance for Grade I cases: of these
attending hospital within six weeks of the first symptom. 92 per cent survive five
vears, compared with 72 per cent waiting six to twelve months. In contrast,
there is little difference in outlook for patients with Grade II tumours for similar
intervals of time. In the case of the highest grade of carcinoma there is a negli-
gible fall in results with increasing delay. The survival rate in this group is 29
per cent for patients seeking treatment within six weeks of the onset, compared
with 25 per cent for those waiting six to twelve months. WVe are thus faced with
the fact that by the time a highly malignant growth (Grade III) is discovered by
the patient it is, in all probability, too late to eradicate, direct extension and
metastasis having already taken place.
It must be pointed out, however, that many women with Grade III cancers
who present early appear, from the clinical aspect, to have a favourable outlook.
Why then is disaster so frequent in these cases ? The theory is held here that
such cases, in reality, are sub-clinically advanced, small tumour emboli probably
having already reached regional glands and bone. Such deposits have not yet
had time to grow and become evident. Even routine histological examination of
axillary glands removed by the radical mastectomy may fail to reveal their
presence. Saphir and Amromin (1948), by serial sections, have demonstrated
cancer cells in the axillary glands in about one-third of cases previously reported
as being free from invasion.
We are compelled to adopt the view that outcome in mammary- carcinoma is
determined largely by the histological type of growth. rather than by prompt
treatment as soon as the lesion is discovered. Macdonald (1942) expresses a
similar opinion when he states that ' natural selection ' is more important in
prognosis thanearlytherapy. Kunath (1940) considers that " therate ofgrowth"'
is the major factor influencing end-results rather than the length of time the
tumour has been present. In fact, Nathanson and WVelch (1936) believe that
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patients with the shortest delay in treatment have the worst prognosis! This
unorthodox view is based upon evidence which suggests that patients with
tumours of slow growth tend to seek medical aid much later than those with ones
ofrapid growth; some support for this has been found in Tables VIII and IX.
Certain authors have shown a sudden increase in the five-year results when
the duration of symptoms reaches oneyear or longer. This has been the ex-
perience ofEggers, deCholnoky andJessup(1941).M3acdonald(1942) and Harnett
(1948). In the present series no such increase was observed when the patients
were taken as a whole (Table V). On the other hand, aslight improvement was
demonstrated by considering thecases according to histological grade (Table X).
This only applied to the carcinomas belonging to the low and intermediate grades
of malignancy. It is postulated that these tumours of long duration were of
particularly slow growth and, therefore, did not alarm the patients sufficiently to
visit their doctors until after a considerable length of time had elapsed.
WVhat conclusions can be reached here regarding the duration of symptonis
andprognosis in breast cancer? Pleas are for ever being made for the education
of the public and general practitioner with a view to shortening the delay in
seeking treatment after the onset of the first symptom. This may appear to be
justifiable when it is remembered that, even in modern communities subject to
press and radio propaganda, there are still. at the best, only some 60 per cent of
patients who present within six months of discovering a lump in the breast.
Lost time, however. has been shown here to be ofimportance only for tumours of
low grade malignancy. With regard to the most virulent growths (GradeIII)
this factor appears to be oflittle or no significance. The theory is put forward
that by the time such a tumour is discovered by the patient it has already spread
beyond the breast.
Perhaps we may now refer briefly to certain clinical implications arising from
our investigation. WN'hat can be done to improve the prognosis of the Grade III
cases? It would appear that the favourable stage for the treatment of this type
ofgrowthislong before it is foundby thepatient. Frequent routine examinations
ofthe breasts would, in all probability, lead to its earlv discovery, and perhaps a
better chance for attaining a five-year survival. Several surgeons have suggested
such a plan. Indeed, Hawkins (1944) has gone so far as to advocate that every
woman should betaught to inspect andpalpate her own breasts, and that such an
examination be made not less than once a month. Chase (1947) voices a similar
opinion. When it is recalled that about 7,000 women in this country and 15,000
in the United States of America die annually from breast cancer, some mav
consider this procedure to be warranted. Others, for fear of producing a wide-
sprea.d cancer neurosis, would rather direct energy to improving the treatment of
the disease.
Doubt has been expressed as to the value of surgical treatment, purely on
account ofalong history (Davis, 1938). From the evidence presented in Table X
it wouldappear that such a view is not onlvfallacious, but alsoextremely danger-
ous; ofthe patients withsymptoms lasting one year or more, over three-quarters
of those belonging to Grade I andfully a half ofthose of Grade II were alive five
years after operation.
In conclusion: we believe that campaigns aimed at shortening the delay
before seeking medical advice should not only be continued, but also intensified,
ifonlyforthe sake ofthosepatientshavingtumours oflowhistologicalmalignancy.
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It is most important, however, to realize that such measures alone must not be
relied upon to increase the number of five-and ten-year survivors. We have
revealed that the prognosis of certain cases does not appear to be materiallv
influenced by the institution of early therapy. In fact, it is misleading to state,
as so often is done, that the outlook is usually good for patients who present
promptly after the onset of svmptoms.
SITE OF TTMOUR AND PROGNOSIS.
Before investigating the relationship between site of growth and prognosis in
breast carcinoma, let us first examine the frequency with which various parts of
the gland are involved by this disease.
The incidence ofcancer in either breast appears to be about equal. A number
of reports, however, suggest a slight preponderance, to the extent of 4 or 5 per
cent, for the left side over the right (Luff, 1932; W,evill, 1932; Busk and Clem-
mesen, 1947 ; Harnett, 1948).
The region of the breast affected was studied in the present series, the usual
subdivisions into quadrants, axillary tail and centre being made. Adequate
information regarding the site ofthe growth was available in 441 cases. In 52 of
these the tumour was described as being situated in a hemisphere, or in the mid-
line of two adjacent quadrants. Four patients were said to have more than one
lump in different quadrants of a single breast. It was thought best to exclude
these 56 cases from the series, leaving 385 for consideration. The distribution
ofthe tumours, which is drawn out in Table XI, reveals a well-marked preponder-
ance of the upper outer quadrant of the breast as the site for mammary cancer.
TABLE XI.-Inidence of Breat Carcinoma According to Site (Mfiddlesex
Hospital).
Present series Campiche and Barlow, 1905 Beckton, 1909 Truscott, 1947
(1936 to 1942) (1747 to 1903) (1904 to 1909) (1926 to 1935)
Site. 385 cases. 1010 cases. 230 cases. 836 cases.
Cases. Per cent. Per cent. Per cent. Per cent.
LTpper outer . 177 46 . 45 . 46 . 46
Upper inner . F75 19 . 17 . 20 . 20
Central . 35 9 . 20 . 15 . 13
Lower outer. 54 14 . 12 . 13 . 12
Lower inner. 19 5 . 6 . 5 . 5
Axillarv tail. 7 2 . - . 1 . 4
Diffuse or
whole breast 18 5 . - - .
Total . 385 100 . 100 . 100 . 100
The frequencies given here for the different regions agree verv closely with those
of previous workers at the MIiddlesex Hospital, also shown in Table XI. The
somewhat higher incidence of central" growths found by Campiche and
Lazarus-Barlow (1905), Beckton (1909) and Truscott (1947) is probably accounted
for by the inclusion in this group of large growths involving three or more quad-
rants. WVe have preferred to classify these separately under the heading of
"diffuse " or " whole breast." The results obtained at this hospital differ in no
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way from those reported elsewhere (Lane-Claypon, 1924; Luff, 1932; Wevill,
1932; Geschickter, 1945; Harnett, 1948).
Having noted the frequency with which the various parts of the breast are
the seat of cancer, we will now consider whether these sites have any prognostic
significance. Many opinions have been expressed, but there is no general agree-
ment on this point. Handley (1922, 1927) was the first to stress the importance
of the internal mammary chain of lymph glands as an avenue of extension for
malignant cells to the thorax and abdomen. Because of the proximity to these
surgically inaccessible nodes, carcinomas arising in the inner halfofthe breast are
alleged by some authors, such as Bartlett (1933) and Hawkins (1944), to carry a
more gloomy prognosis than those situated in the outer hemisphere.
It has also been stated that cancer in the upper outer-or lower inner quadrants
is more likelv to prove fatal at an early date. the former being in close relation to
the axillary lymph glands and the latter to the abdominal viscera. A similar
opinion has been expressed for tumours in the region of the nipple, owing to the
presence of the sub-areolar plexus of Sappey which drains to the axilla. Lane-
Claypon (1924) found support for these views in a group ofsome 300 cases. This
same author, however, in a later, more extensive study (Lane-Claypon, 1928)
was unable to confirm her previous results, and finallv decided that there is no
evidence that the prognosis varies according to the site.7' More recently, Truscott
(1947) and also Harnett (1948) have reached a similar conclusion.
The relationship between site and survival rate was examined in the present
series, the results being shown in Table XII. Owing to the very small number of
TABLE XII.-Site and Prognosis.
5-year survivals.
Site. Cases. No. Per cent.
Upper outer . 177 . 92 52
Lower outer . 54 . 31 57
Central . . 35 . 15 43
Upper inner . 75 . 35 47
Lower inner . 19 . 9 47
Axillarv tail . 7 . 1 14
Diffuse or
whole breast 18 . 3 17
Total . 385 . 186 48
examples, we cannot consider the prognostic significance of axillary tail involve-
ment. The cases classified as " diffuse " or " whole breast " appear to have a
bad outlook, a mere 17 per cent surviving five years. As for the other sites, there
is no striking variation in the results. It is possible that growths situated in the
sternal quadrants and in the nipple area carry a slightly worse prognosis than do
those in the outer regions.
A broader grouping of cases will now be considered, depending on whether
the inner or outer hemisphere ofthe breast is the seat ofthe tumour (Table XIII).
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TABLE XXIII.-Site and Prognosis.
Site. ca.988. 5-year survivals.
No. Per cent.
Inner hemisphere . 94 . 44 47
Outer hemisphere . 243 . 130 53
The survival rate is again seen to be less for the inner region, but the difference is
very small and therefore of doubtful significance. Consequently, we have not
been able, so far, to prove that tumours situated in the sternal half ofthe breast
carry a more gloomy outlook than those in the axillary half. In fact, a previous
writer from this Hospital (Truscott, 1947) found that patients with growths in
the lower inner quadrant had the lowest mortality.
When we have been previously faced with conflicting opinions on various
aspects of breast cancer, considerable assistance has been obtained by studying
themorbidhistology ofourcases. Let us, therefore, apply theprincipleofgrading
to the present problem.
First of all, what types of cases are present in the various groups we have
considered in Table XII ? The distribution according to the grade ofmalignancy
is shown for each site in Table XIV.
TABLE XIV.-Incidence of the Three Grades of Tunwur According to the Part
of the Breast Involved.
Cases per cent.
Grade. Quadrant.
Axilry taiL. Central. Diffuse. Upper Upper Lower Lower
outer. inner. outer. inner.
I . 0 . 37 . 11. 31 . 30 . 30 . 32
II . 29 . 40 . 28. 44 . 41 . 40 . 36
III . 71 . 23 . 61. 2 . 29 . 30 . 32
Total. 100 100.100(. 100 .100 .100 .100
It is evident that the poor prognosis for the small number of patients with
axillary tail growths could be entirely accounted for by the preponderance of
highly malignant tumours in this group, there being 71 per cent Grade III but
no Grade I cases.
A study of those patients classified as having " diffuse " cancers shows a
similar state ofaffairs. In this instance 61 per cent ofthe patients had Grade III
tumours, whilst only 11 per cent were Grade I. The widespread nature of these
growths and the poor prognosis would, therefore, appear to depend upon the high
incidence of extremely malignant tumours.
Further examination ofTable XIV reveals that, in contrast to the " axillary"
and " diffuse " tumours, the proportion ofthe three types ofcancer in the central
and various quadrant positions of the breast is very similar. Hence, in these
cases we cannot evoke the distribution of the tumours to account for the slight
differences in the five-year survival rates.PROGNOSIS OF BREAST CARCINOMA 3
Withregard tothe casesseparated outaccording to inner andouterhemisphere
involvement (Table XIII), the scatter of the cases in each group is again seen to
be similar (Table XV).
TABLE XV.-Incidence of the Three Grades of Tununr According to Inner or




I . 31 . 31
II . 41 . 39
III . 28 . 30
Total . 100 . 100
Let us now reconsider the problem ofsite and prognosis, but this time taking
into account the grade of malignancy. To avoid breaking the cases up into too
many small groups, onlv inner and outer hemisphere growths will be studied.
The results of this investigation are laid out in Table XVI. It is interesting to
TABLE XVI.-Site, Grade and Prognosi8.
Outer hemisphere. Inner hemisphere.
~-vear Grade. e5 a-year
Cas-es. survivors. Cases. survivors.
No. Per cent. No. Per cent.
I . 76 . 65 86 . 29 . 21 72
II . 100 . 47 47 . 37 . 15 41
III . 6#7 . 18 27 . 28 . 8 29
note that site may be of some importance for Grade I carcinomas, the outlook
being slightly worse when the inner halfofthe breast is involved. The difference
for the intermediate cases is very small and of doubtful significance. Tumours
ofhigh grade malignancy are seen to have an equally bad prognosis whether they
are situated in the inner or outer regions.
We conclude from the present investigation that, generally speaking, site of
tumour in breast cancer exerts no striking effect on prognosis, apart from those
patients in whom the growth involves a large part ofthe gland, and this is largely
determined by the histological type of neoplasm (i.e. Grade III). On the other
hand, the outlook for the women with centrally placed growths may be slightly
less favourable than for those with quadrant tumours, presumably because of
their close proximity to the sub-areola lymphatic plexus of Sappey. Cases of
low grade malignancy may be influenced to a minor degree by the site of the
growth, depending upon whether the sternal or axillary half of the breast is
affected (Table XVI). The reason for this may be as follows. Site is of no
consequence for Grade III tumours owing to their tendency to metastasize early
no matter where they are situated, rapid, wide-spread secondary deposits appear
to be the rule. In contrast to this, Grade I tumours disseminate much less
readily. Hence site becomes important, the nearer these growths are to inac-
*361H. J. G. BLOOM
cessiblechannelsofspread (e.g. internalmammarvchain), the greaterthe likelihood
ofsuch secondary involvement having taken place before the primary is removed.
SIZE OF TUMOUR A-D PROGNOSIS.
Canthe size ofthe tumourprove ofanyvalueinassessing outcome inmammary
carcinoma ? Geschickter (1945) points out that this feature is seldom discussed,
although it is usually agreed that cancer occupying the entire gland is most
frequently hopeless. Inthe present series there were 18 cases in which the growth
was described as being "'diffuse ' or occupying the " whole breast," and of these
only 17 per cent survived five years. Such cases are now rarely seen. What of
the prognostic significance of smaller, less advanced growths ? Here again. as
with so many other aspects of breast cancer, opinions do not agree.
Kunath (1940) failed to find a correlation between size of tumour and prog-
nosis. A similar result was obtained by Hoopes and McGraw (1942). On the
other hand, Eggers, de Cholnokv and Jessup (1941) showed a five-year survival
rate of 73 per cent for patients with neoplasms of 2 cm. or less. With an increase
ofsize (3 to 6 cm.) the survivals dropped to 24 per cent. reaching 16 per cent for
the largest growths (7 cm. or more).
Inthe present study information regarding the size ofthe tumourwas available
in 350 cases. These were separated out into three groups and the survival rates
determined (Table XVII). An examination of this table reveals that the prog-
nosis deteriorates as the tumour increases in size.




I'orless. 172 . 101 59
I"-2" .141 . 64 45
> 2 . 37 . 12 32
Sofar, we have considered the cases as a whole, no allowance having been made
for the different types of growth. The importance of taking this into account is
obvious. Forexample, itwouldbefallaciousto compare asmall, highly malignant
growth with one of large dimensions, but of low grade malignancy. Geschickter
(1945) also refers to this point-" the size of the tumour is a reliable index of
prognosis only ifthe pathological type is taken into consideration." It therefore
follows that the better outlook for smaller turmours may result from a greater
proportion ofcases oflow grade malignancy existing in this group. The converse
would apply to the larger growths, here there being a preponderance of highly
malignant examples. This, indeed, was found to be the case in the present
investigation (Table XVIII). Of the tumours with a diameter of 1 inch or less.
37 per cent are classified as Grade I and 23 per cent as Grade III. On the other
hand, in the case ofgrowths ofmore than 2 inches diameter only 8 per cent belong
to Grade I whilst 54 per cent are Grade III. When the diameter lies between
1 and 2 inches the incidence of these tumours is practicallv the same.
The distribution of cases as shown in Table XVIII once again emphasizes the
importance of the histological type of growth in cancer of the breast. A further
study must therefore be made in which attention is given to size and prognosis
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Orless . I . 64 37
H . 68 40
II . 40 23
Total . 172 100
I . 39 28
I . 67 47
III . 35 25
Total . 141 100
>2w . I . 3 8
II . 14 38
III . 20 54
Total . 37 100
according to grade of malignancy. Owing to the small number of patients with
tumours over 2 inches in diameter, only two groups of cases will be considered
instead ofthe originalthree-those withgrowths below and above 1 inch diameter.
Table XIX reveals the five-year survivals according to size and grade. It is
TABLE XIX.-Grade, Size and Prognoss.
Grade. Size. casm 5-year survivals.
Grade. Size. Ca4es. _
No. Per cent.
I . lTorless . 64 . 49 77
>1 . 42 . 33 79
HI . 1 or less . 68 . 40 59
>1f .81 . 27 33
HII . 1 or less . 40 . 12 30
>1 . 55 . 16 29
Total . 350 . 177 50
evident that size appears to be of no prognostic significance with regard to car-
cinomas of either low or high malignancy. Wihether the tumours are small or
large, the outlook is uniformly good in the former and bad in the latter group.
On the other hand, an intermediate result is obtained for the intermediate cases
(Grade II), the survival rate being practically halved in the presence ofthe larger
neoplasms. In other words, the metastasizing power for Grade I and also Grade
m cancers is independent of size. For growths classified as Grade H this power
bears a direct relationship to the diameter, the larger the tumour the greater the
likelihood of spread having taken place.
We consider that the conflicting opinions expressed regarding the relationship
between size of tumour and prognosis in mammary carcinoma result from the
study ofhistologically incomparable groups of cases.
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PREGNA-NCY OR LACTATION AND PROGNOSIS.
It is now generally believed that breast cancer,whenassociated withpregnancy
orlactation, isparticularly virulant and bears abadprognosis. This complication
was not reported as being present in any ofthe cases in the present investigation.
For the sake of completeness, however, brief attention will be given to this
feature by referring to the work of other authors.
The gloomv outlook for these patients is well supported by Lee (1931) who,
in a small group of 25 cases, finds only 8 per cent alive and well three years after
operation. A larger investigation was carried out by Harrington (1937). He
studied 92 examples of mammary carcinoma in pregnancy or lactation treated at
the Mayo Clinic between the years 1910 and 1933. The five-year survival rate
was 15 per cent compared with 44 per cent in the larger general series from the
same centre. Axillarv metastases occurred in 85 per cent of the patients (64 per
cent inthegeneral series), thuslending furtherweight to the view that the tumours
of such cases are more malignant and spread more rapidly than do those which
are not associated with pregnancy. The prognosis was practically hopeless for
patients with involvement of the axilla, a mere 6 per cent surviving five years
(28 per cent in the general series). On the other hand, pregnancy or lactation
in the absence ofthis complication did not appear to effect the outcome adversely,
there being 62 percent five-yearsurvivals compared with 72 percent inthe general
survey.
More recently, Richards (1948) reports a five-year survival rate of 25 per cent
for a small group of cases compared with 43 per cent in his general series. It
appears that the very grave prognosis for these patients has been improved by
the addition of irradiation to surgical treatment (Cade, 1950).
WA-hat is required now is a histological study to determine the incidence of
the different types of breast cancer occurring in pregnancy. If the tendency
is towards a high degree of malignancy, and this would appear to be the case
from the clinical data, then a preponderance of Grade III cases is to be expected.
Unfortunately, this view cannot be confirmed at the present time owing to the
lack of material. It is intended, however, to undertake such a studv at a later
date. Meanwhile, we may refer again to Harrington (1 937). This author graded
the tunours of 80 ofhis cases according to the method ofBroders (which is based
onfourgrades), andfoundthat practically all wereofa high degree ofmalignancy;
in point of fact, there was not a single instance of a Grade 1 case and only 6 per
cent belonged to Grade 2, whereas 25 per cent were of Grade 3 and 69 per cent of
Grade 4. (Table XX.)
TABLE XX.-Distribison ofCases in Pregnancy According to Grade of
Malignancy (Harrinton, 1937).
Broders'
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It is of interest to note that pregnancy following the adequate control of a
previous mammary carcinoma does not appear to influence the outlook adversely.
Thus intheinvestigation by Harrington (1937) there were 55 cases in such circum-
stances, and 79 per cent were alive at the end of five years. The percentage of
survivals for patients with and without axillary metastases was 57 and 97 respec-
tively. But in spite ofthese excellent results, Harrington considers it inadvisable
for women who have been treated for breast cancer to undergo a subsequent
pregnancy.
CONCLUSIONS.
A number of clinical factors which have been claimed to influence prognosis
in carcinoma of the breast have been examined. We believe that much of the
controversy which centres around these problems has developed as the result of
studying groups ofcases which are not comparable from the histological point of
view.
The importance of the microscopic appearance of the tumour in classifying
and assessing the prognosis ofpatients with breast cancer has been stressed else-
where (Bloom, 1950). This feature has been taken into account in the present
investigation, and from the results we conclude that, in spite ofwidely held views
to the contrary, the age of the patient, the duration of symptoms and the site
of the primary growth exert little or no influence on the ultimate outcome. A
prognostic factor offargreater importance would appear to be the type oftumour
as determined by a histological grading system-a factor which, unfortunately,
is almost entirely neglected at the present time.
From this and our previous work the assistance that can be given by the
pathologist to those dealing with the clinical aspects of breast cancer is obvious.
We consider that many ofthe problems which have arisen concerning the results
of treatment ofthis disease depend upon the inaccurate grouping of cases. It is
hoped that the wider use of morbid histology will help to reduce this source of
error to a minimum, and so enable us to assess the true merits ofthe various lines
of therapy; this is our ultimate aim.
SUMMARY.
1. The present work is a continuation of the investigation into the problems
of prognosis in mammary carcinoma reported recently in this Journal (Bloom,
1950).
2. The relationship between the age ofthe patient and prognosis was studied.
No significant differences in outcome were revealed in the various age groups,
the younger women faring no worse than the older ones. These findings were
confirmed by the fact that the incidence of tumours of low and also of high
malignancy in the various decades was practically the same.
3. It is useless to try to assess the effect of the delay in seeking treatment
without reference to the histological type of growth involved. For example,
delayisoflittleimportanceforpatientswithhighlymalignant (Gradem)tumours;
it does not seem to matter whether such cases attend for treatment early (less
than 6 weeks) or late (6 to 12 months), theprognosis isequally bad. On the other
hand, the time factor appears to influence the outlook of women with growths
whose behaviour is essentially more benign (Grade I). In this type ofcase a loss
ofmore than 6 months means a substantial fall in the survival rate.
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4. The site of the tumour in the breast was, generally speaking, found to
exert no striking effect on prognosis. However, it is possible that the outlook
for patients with growths of low grade malignancy may be influenced slightlv
by this feature, depending on whether the medial or lateral hemispheres are
involved.
5. WNThen the patients were considered as a whole the size of the primary
growth was found to influence prognosis, the larger the tumour the lower the
survival rate. It is in the intermediate grade of tumours that these differences
are especially found, and it is cases of this grade that are largely responsible for
the general result. Size was evidently of no prognostic importance for women
with tumours of a low and also a high grade of malignancy. It did not appear
to matter whether the growths were small or large, the outlook was uniformlv
good in the former and bad in the latter group. In contrast to this, the prognosis
for neoplasms ofan intermediate degree of malignancy showed marked deteriora-
tion with increase of size.
6. Brief reference has been made to the progress of cases of breast cancer
when associated with pregnancy or lactation.
Note by T.E. Cowan, Esq., F.C.I.S., F.R.S.S.: The inferences drawn from the
tables shown are statistically sound.
I must again express my indebtedness to Professor R. W. Scarff for introduc-
ing me to his system of histological grading of breast cancer and for encourage-
ment; to Dr. A. C. Thackray for kind advice ; to M1r. T. E. Cowan for checking
the statistics, and to Miss J. Chambers, of the Follow-up department, for tracing
the patients.
Forthe cases employed inthis work I amgrateful tothesurgeons oftheMNiddle-
sex Hospital and its War-time Sector Units, and to Professor B. W. Windever
of the MIeyerstein Institute of Radiotherapy.
The expenses ofthis investigation were defraved by the British Empire Cancer
Campaign.
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